Our top pick for
Pactiv Evergreen Inc is a packaging & containers business based in the US. Pactiv Evergreen shares (PTVE) are listed on the NASDAQ and all prices are listed in US Dollars. Pactiv Evergreen employs 15,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$13.16|
|52-week range||$10.57 - $19.22|
|50-day moving average||$12.19|
|200-day moving average||$14.13|
|Wall St. target price||$14.00|
|Dividend yield||$0.2 (1.56%)|
|Earnings per share (TTM)||$-0.78|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||3.79%|
|1 month (2021-09-23)||18.24%|
|3 months (2021-07-23)||-6.67%|
|6 months (2021-04-23)||-6.86%|
|1 year (2020-10-22)||-3.09%|
|2 years (2019-10-19)||N/A|
|3 years (2018-10-19)||N/A|
|5 years (2016-10-19)||N/A|
Valuing Pactiv Evergreen stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pactiv Evergreen's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pactiv Evergreen's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $587 million.
The EBITDA is a measure of a Pactiv Evergreen's overall financial performance and is widely used to measure a its profitability.
To put Pactiv Evergreen's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$4.9 billion|
|Operating margin TTM||5.92%|
|Gross profit TTM||$710 million|
|Return on assets TTM||1.9%|
|Return on equity TTM||-8.36%|
|Market capitalisation||$2.2 billion|
TTM: trailing 12 months
There are currently 1.0 million Pactiv Evergreen shares held short by investors – that's known as Pactiv Evergreen's "short interest". This figure is 17.6% up from 889,476 last month.
There are a few different ways that this level of interest in shorting Pactiv Evergreen shares can be evaluated.
Pactiv Evergreen's "short interest ratio" (SIR) is the quantity of Pactiv Evergreen shares currently shorted divided by the average quantity of Pactiv Evergreen shares traded daily (recently around 162432.29813665). Pactiv Evergreen's SIR currently stands at 6.44. In other words for every 100,000 Pactiv Evergreen shares traded daily on the market, roughly 6440 shares are currently held short.
To gain some more context, you can compare Pactiv Evergreen's short interest ratio against those of similar companies.
However Pactiv Evergreen's short interest can also be evaluated against the total number of Pactiv Evergreen shares, or, against the total number of tradable Pactiv Evergreen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pactiv Evergreen's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Pactiv Evergreen shares in existence, roughly 10 shares are currently held short) or 0.0246% of the tradable shares (for every 100,000 tradable Pactiv Evergreen shares, roughly 25 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Pactiv Evergreen.
Find out more about how you can short Pactiv Evergreen stock.
Dividend payout ratio: 41.43% of net profits
Recently Pactiv Evergreen has paid out, on average, around 41.43% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.12% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Pactiv Evergreen shareholders could enjoy a 3.12% return on their shares, in the form of dividend payments. In Pactiv Evergreen's case, that would currently equate to about $0.2 per share.
While Pactiv Evergreen's payout ratio might seem fairly standard, it's worth remembering that Pactiv Evergreen may be investing much of the rest of its net profits in future growth.
Pactiv Evergreen's most recent dividend payout was on 14 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 30 August 2021 (the "ex-dividend date").
Pactiv Evergreen's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Pactiv Evergreen Inc. manufactures and distributes fresh foodservice and food merchandising products, and fresh beverage cartons in North America. It operates through three segments: Foodservice, Food Merchandising, and Beverage Merchandising. The Foodservice segment offers food containers, hot and cold cups, lids, dinnerware, and other products. The Food Merchandising segment provides clear rigid-display containers, containers for prepared and ready-to-eat food, trays for meat and poultry, and molded fiber cartons. The Beverage Merchandising segment offers cartons for fresh refrigerated beverage products. This segment also provides integrated fresh carton systems, which include printed cartons with high-impact graphics, spouts, and filling machines, as well as fiber-based liquid packaging board and range of paper-based products.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.